Original Article

You have full text access to this OnlineOpen article

Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix†

  1. James V. Lacey Jr. Ph.D.1,¶,*,
  2. Christine A. Swanson Ph.D.1,‡,
  3. Louise A. Brinton Ph.D.1,
  4. Sean F. Altekruse D.V.M.1,
  5. Willard A. Barnes M.D.2,
  6. Patti E. Gravitt Ph.D.3,§,
  7. Mitchell D. Greenberg M.D.4,
  8. Olympia C. Hadjimichael M.S.5,
  9. Larry McGowan M.D.6,
  10. Rodrigue Mortel M.D.7,
  11. Peter E. Schwartz M.D.5,
  12. Robert J. Kurman M.D.8,
  13. Allan Hildesheim Ph.D.1

Article first published online: 14 JUL 2003

DOI: 10.1002/cncr.11567

Issue

Cancer

Cancer

Volume 98, Issue 4, pages 814–821, 15 August 2003

Additional Information

How to Cite

Lacey, J. V., Swanson, C. A., Brinton, L. A., Altekruse, S. F., Barnes, W. A., Gravitt, P. E., Greenberg, M. D., Hadjimichael, O. C., McGowan, L., Mortel, R., Schwartz, P. E., Kurman, R. J. and Hildesheim, A. (2003), Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer, 98: 814–821. doi: 10.1002/cncr.11567

Author Information

  1. 1

    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland

  2. 2

    Department of Obstetrics and Gynecology, Lombardi Cancer Center, Georgetown University, Washington, DC

  3. 3

    Department of Human Genetics, Roche Molecular Systems, Inc., Alameda, California

  4. 4

    Department of Gynecology, Graduate Hospital, Philadelphia, Pennsylvania

  5. 5

    Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut

  6. 6

    Division of Gynecologic Oncology, George Washington University, Washington, DC

  7. 7

    Department of Obstetrics and Gynecology, Milton S. Hershey Medical Center, Hershey, Pennsylvania

  8. 8

    Departments of Gynecology, Obstetrics and Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland

  1. §

    Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

  2. ‡

    Office of Disease Prevention, Office of the Director, National Institutes of Health, Bethesda, Maryland

  1. Fax: (301) 402-0916

*Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, MSC 7234, Rockville, MD 20852-7234

  1. †

    This article is a US Government work and, as such, is in the public domain in the United States of America.

Publication History

  1. Issue published online: 1 AUG 2003
  2. Article first published online: 14 JUL 2003
  3. Manuscript Accepted: 13 MAY 2003
  4. Manuscript Revised: 28 APR 2003
  5. Manuscript Received: 13 DEC 2002

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (91K)

REFERENCES

  • 1
    Peto J. Cancer epidemiology in the last century and the next decade. Nature. 2001; 411: 390–395.
  • 2
    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003; 348: 1625–1638.
  • 3
    Key TJ, Allen NE, Verkasalo PK, Banks E. Energy balance and cancer: the role of sex hormones. Proc Nutr Soc. 2001; 60: 81–89.
  • 4
    Albanes D. Caloric intake, body weight, and cancer: a review. Nutr Cancer. 1987; 9: 199–217.
  • 5
    Wolk A, Gridley G, Svensson M, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control. 2001; 12: 13–21.
  • 6
    Ursin G, Pike MC, Preston-Martin S, d'Ablaing G, Peters RK. Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: results from a population-based case–control study (California, United States). Cancer Causes Control. 1996; 7: 391–401.
  • 7
    Parazzini F, La Vecchia C, Negri E, Fasoli M, Cecchetti G. Risk factors for adenocarcinoma of the cervix: a case–control study. Br J Cancer. 1988; 57: 201–204.
  • 8
    Parazzini F, La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol. 1990; 39: 40–46.
  • 9
    Kjaer SK, Brinton LA. Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem. Epidemiol Rev. 1993; 15: 486–498.
  • 10
    Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Parkin DM. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer. 1998; 75: 536–545.
    Direct Link:
  • 11
    Brinton LA, Tashima KT, Lehman HF, et al. Epidemiology of cervical cancer by cell type. Cancer Res. 1987; 47: 1706–1711.
  • 12
    Brinton LA, Herrero R, Reeves WC, DeBritton RC, Gaitan E, Tenorio F. Risk factors for cervical cancer by histology. Gynecol Oncol. 1993; 51: 301–306.
  • 13
    Abad RS, Kurohara SS, Graham JB. Clinical significance of adenocarcinoma of the cervix. Am J Obstet Gynecol. 1969; 104: 517–522.
  • 14
    Milsom I, Friberg LG. Primary adenocarcinoma of the uterine cervix. A clinical study. Cancer. 1983; 52: 942–947.
    Direct Link:
  • 15
    Hopkins MP, Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol. 1991; 77: 912–917.
  • 16
    Korhonen MO. Epidemiological differences between adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 1980; 10: 312–317.
  • 17
    Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55: 244–265.
  • 18
    Munoz N, Franceschi S, Bosetti C, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case–control study. Lancet. 2002; 359: 1093–1101.
  • 19
    Moreno V, Bosch FX, Munoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case–control study. Lancet. 2002; 359: 1085–1092.
  • 20
    Lacey JV Jr., Brinton LA, Abbas FM, et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev. 1999; 8: 1079–1085.
  • 21
    Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol. 1998; 36: 3020–3027.
  • 22
    van den Brule AJ, Class EC, du Maine M, et al. Use of anti-contamination primers in the polymerase chain reaction for the detection of human papilloma virus genotypes in the cervical scrapes and biopsies. J Med Virology. 1989; 29: 20–27.
    Direct Link:
  • 23
    Gravitt PE, Lacey JV Jr., Brinton LA, et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev. 2001; 10: 95–100.
  • 24
    Swanson CA, Coates RJ, Schoenberg JB, et al. Body size and breast cancer risk among women under age 45 years. Am J Epidemiol. 1996; 143: 698–706.
  • 25
    Okosun IS, Tedders SH, Choi S, Dever GE. Abdominal adiposity values associated with established body mass indexes in white, black and Hispanic Americans. A study from the Third National Health and Nutrition Examination Survey. Int J Obes Relat Metab Disord. 2000; 24: 1279–1285.
  • 26
    Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, 1989.
  • 27
    SAS Institute Inc. SAS software: changes and enhancements, release 6.11. Cary: SAS Institute Inc., 1995.
  • 28
    Altekruse SF, Lacey JV Jr., Brinton LA, et al. Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. Am J Obstet Gynecol. 2003; 188: 657–663.
  • 29
    Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr. 2002; 75: 683–688.
  • 30
    Michels KB, Greenland S, Rosner BA. Does body mass index adequately capture the relation of body composition and body size to health outcomes? Am J Epidemiol. 1998; 147: 167–172.
  • 31
    Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol. 1989; 129: 1120–1131.
  • 32
    Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr. 1987; 45: 277–282.
  • 33
    Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control. 2001; 12: 47–59.
  • 34
    Wee CC, McCarthy EP, Davis RB, Phillips RS. Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? Ann Intern Med. 2000; 132: 697–704.
  • 35
    Lubitz RM, Litzelman DK, Dittus RS, Tierney WM. Is obesity a barrier to physician screening for cervical cancer? Am J Med. 1995; 98: 491–496.
  • 36
    Mitchell H, Medley G, Gordon I, Giles G. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit. Br J Cancer. 1995; 71: 894–897.
  • 37
    Shingleton HM. Do squamous cell carcinomas and adenocarcinomas of the cervix have the same risk factors? Gynecol Oncol. 1993; 51: 299–300.
  • 38
    Wright TC, Ferenczy A, Kurman RJ. Carcinoma and other tumors of the cervix. In: KurmanRJ, editor. Blaustein's pathology of the female genital tract, 4th ed. New York: Springer-Verlag, 1994: 279–326.
  • 39
    Nieto-Garcia FJ, Bush TL, Keyl PM. Body mass definitions of obesity: sensitivity and specificity using self-reported weight and height. Epidemiology. 1990; 1: 146–152.
  • 40
    Kuczmarski MF, Kuczmarski RJ, Najjar M. Effects of age on validity of self-reported height, weight, and body mass index: findings from the Third National Health and Nutrition Examination Survey, 1988–1994. J Am Diet Assoc. 2001; 101: 28–34.
View Full Article (HTML) Get PDF (91K)